Effects of a tamoxifen-norethisterone combination in 16 patients with hepatocellular carcinoma
Trinchet, J.C.; Roudil, F.; Vaysse, J.; Beaugrand, M.
Gastroenterologie Clinique et Biologique 9(5): 455-456
1985
ISSN/ISBN: 0399-8320 PMID: 2989070 Document Number: 253239
Document emailed within 1 workday
Related Documents
Takada, N. 1990: Effects of combination therapy with hyperthermia and immuno-targeting chemotherapy using anti-AFP antigen on hepatocellular carcinoma Hokkaido Journal of Medical Science 65(4): 384-391Akahane, Y. 2001: Hepatocellular carcinoma in patients with parasitic liver disease--Japanese schistosomiasis and hepatocellular carcinoma Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 6): 474-477
Täuber, U.; Hümpel, M. 1984: Distribution of norethisterone and ethinylestradiol in the gravid rat and in the feto-placental unit of rhesus monkeys following intragastric administration of norethisterone acetate in combination with ethinylestradiol. II. Autoradiography Arzneimittel-Forschung 34(5): 590-596
Spritzer, P.M.; Barbosa-Coutinho, L.M.; Poy, M.; Orsi, V.; Dahlem, N.; Silva, I.S. 1995: Effects of norethisterone acetate and tamoxifen on serum prolactin levels, uterine growth and on the presence of uterine immunoreactive prolactin in estradiol-treated ovariectomized rats Brazilian Journal of Medical and Biological Research 28(1): 125-130
Sakon, M.; Monden, M.; Gotoh, M.; Kobayashi, K.; Kanai, T.; Umeshita, K.; Endoh, W.; Mori, T. 1991: The effects of vitamin K on the generation of des-gamma-carboxy prothrombin (PIVKA-II) in patients with hepatocellular carcinoma American Journal of Gastroenterology 86(3): 339-345
Lencioni, R.; Cioni, D.; Donati, F.; Bartolozzi, C. 2001: Combination of interventional therapies in hepatocellular carcinoma Hepato-Gastroenterology 48(37): 8-14
Sonoo, H.; Senoo, T.; Nishiki, M.; Morimoto, T.; Takashima, S. 1996: Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(4): 447-454
Yang, J.; Yan, L.; Wang, W. 2012: Current status of multimodal & combination therapy for hepatocellular carcinoma Indian Journal of Medical Research 136(3): 391-403
Tarao, K.; Ohkawa, S.; Tamai, S.; Shimizu, A. 1995: Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 740-745
Shuqun, C.; Mengchao, W.; Han, C.; Feng, S.; Jiahe, Y.; Wenming, C.; Peiun, W.; Yuxiang, Z. 2004: Combination transcatheter hepatic arterial chemoembolization with thymosin alpha1 on recurrence prevention of hepatocellular carcinoma Hepato-Gastroenterology 51(59): 1445-1447
Kapp, P.; Bély, M.; Nemesánszky, E.; Szende, B. 2001: The role of perisinusoidal (Ito) cells in the course of hepatocellular carcinoma: light and electron microscopic data to the pathogenesis of hepatocellular carcinoma Orvosi Hetilap 142(49): 2741-2746
Rabbani, G.; Benzil, D.; Wallam, M.N.; Chen, B.; Hoang, A.; Kancherla, R.; Ahmed, T. 2007: Combination therapy with thalidomide, temozolomide and tamoxifen improves quality of life in patients with malignant astrocytomas Anticancer Research 27(4c): 2729-2736
Zenali, M.J.; Tan, D.; Li, W.; Dhingra, S.; Brown, R.E. 2010: Stemness characteristics of fibrolamellar hepatocellular carcinoma: immunohistochemical analysis with comparisons to conventional hepatocellular carcinoma Annals of Clinical and Laboratory Science 40(2): 126-134
Ishii, H.; Okada, S.; Sato, T.; Nose, H.; Okusaka, T.; Yoshimori, M.; Takayasu, K.; Takayama, T.; Kosuge, T.; Yamasaki, S. 1996: Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheter arterial embolization Hepato-Gastroenterology 43(9): 644-650
Hu, H.; Chen, C.; Li, H. 2015: Treatment of refractory pulmonary metastases from hepatocellular carcinoma by transcatheter arterial chemoembolization using arsenic trioxide in combination with sorafinib Zhonghua Zhong Liu Za Zhi 37(12): 942-943
Takagi, H.; Abe, T.; Uehara, M.; Saitoh, S.; Takayama, H.; Ojima, T.; Iizuka, H.; Katakai, S.; Takezawa, J.; Nagamine, T. 1988: Effect of combination therapy with an adriamycin-lipiodol emulsion and a mitomycin C microcapsule in hepatocellular carcinoma complicated by portal thrombosis Gan no Rinsho. Japan Journal of Cancer Clinics 34(3): 347-355
Tabarin, A.; Bioulac-Sage, P.; Boussarie, L.; Balabaud, C.; de Mascarel, A.; Grimaud, J.A. 1987: Hepatocellular carcinoma developed on noncirrhotic livers. Sinusoids in hepatocellular carcinoma Archives of Pathology and Laboratory Medicine 111(2): 174-180
Behling, H.; Krafft, W.; Schmeisser, G.; Schirmer, A.; Preibsch, W.; Brückmann, D. 1983: Effectivity of long-term high dose norethisterone treatment of corpus uteri carcinoma patients. Results of a prospective randomized study Zentralblatt für Gynakologie 105(9): 553-559
Semiglazov, V.F.; Maximov, S.Y.; Bulgatova, Y., A.; Meshkova, I.Y.; Chepik, O.F.; Berstein, L.M. 2003: Risk of hyperplasia and endometrial carcinoma in breast cancer patients receiving adjuvant tamoxifen Voprosy Onkologii (Stsburg). 49(2): 198-204
Tsukamoto, T.; Kanazawa, A.; Shimizu, S.; Murata, A.; Sakae, M.; Kurihara, S.; Tashima, T.; Deguchi, S.; Nakai, T.; Kawasaki, Y.; Kioka, K. 2015: Combination Chemotherapy Using Sorafenib and Hepatic Arterial Infusion with a Fine-Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis--A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(12): 1878-1880